Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Bioorganic & Medicinal Chemistry
|
October 25, 2021
Histamine H<sub>3</sub> receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
Markus Falkenstein, David Reiner-Link, Aleksandra Zivkovic, et al.
British Journal of Pharmacology
|
May 10, 2024
Differential G protein activation by the long and short isoforms of the dopamine D<sub>2</sub> receptor
David Reiner-Link, Jakob Sture Madsen, David E Gloriam, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
Discovery of Potential, Dual-Active Histamine H<sub>3</sub> Receptor Ligands with Combined Antioxidant Properties
Kamil J Kuder, Magdalena Kotańska, Katarzyna Szczepańska, et al.
Neuropharmacology
|
June 24, 2022
OLHA (N<sup>α</sup>-oleoylhistamine) modulates activity of mouse brain histaminergic neurons
Olga A Sergeeva, Karolina Mazur, David Reiner-Link, et al.
International Journal of Molecular Sciences
|
March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Bioorganic & Medicinal Chemistry
|
December 21, 2022
Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H<sub>3</sub> and dopamine D<sub>3</sub> receptors
Cecília M S Q Aranha, David Reiner-Link, Luisa R Leitzbach, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 25, 2024
Histamine H<sub>3</sub> receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Silvia Sgambellone, Mohammad A Khanfar, Silvia Marri, et al.
Critical Reviews in Clinical Laboratory Sciences
|
August 9, 2024
G protein-coupled receptor (GPCR) pharmacogenomics
Miles D Thompson, David Reiner-Link, Alessandro Berghella, et al.
European Journal of Pharmacology
|
October 5, 2020
Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H<sub>4</sub> receptor
Marek Grosicki, Maristella Adami, Cristina Micheloni, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 15, 2023
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease
Donia E Hafez, Mariam Dubiel, Gabriella La Spada, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Bioorganic & Medicinal Chemistry
|
October 25, 2021
Histamine H<sub>3</sub> receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation
Markus Falkenstein, David Reiner-Link, Aleksandra Zivkovic, et al.
British Journal of Pharmacology
|
May 10, 2024
Differential G protein activation by the long and short isoforms of the dopamine D<sub>2</sub> receptor
David Reiner-Link, Jakob Sture Madsen, David E Gloriam, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
Discovery of Potential, Dual-Active Histamine H<sub>3</sub> Receptor Ligands with Combined Antioxidant Properties
Kamil J Kuder, Magdalena Kotańska, Katarzyna Szczepańska, et al.
Neuropharmacology
|
June 24, 2022
OLHA (N<sup>α</sup>-oleoylhistamine) modulates activity of mouse brain histaminergic neurons
Olga A Sergeeva, Karolina Mazur, David Reiner-Link, et al.
International Journal of Molecular Sciences
|
March 6, 2021
The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Bioorganic & Medicinal Chemistry
|
December 21, 2022
Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H<sub>3</sub> and dopamine D<sub>3</sub> receptors
Cecília M S Q Aranha, David Reiner-Link, Luisa R Leitzbach, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 25, 2024
Histamine H<sub>3</sub> receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Silvia Sgambellone, Mohammad A Khanfar, Silvia Marri, et al.
Critical Reviews in Clinical Laboratory Sciences
|
August 9, 2024
G protein-coupled receptor (GPCR) pharmacogenomics
Miles D Thompson, David Reiner-Link, Alessandro Berghella, et al.
European Journal of Pharmacology
|
October 5, 2020
Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H<sub>4</sub> receptor
Marek Grosicki, Maristella Adami, Cristina Micheloni, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 15, 2023
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease
Donia E Hafez, Mariam Dubiel, Gabriella La Spada, et al.
Page
of 2